We found that the Cy5.5-conjugated rEgH9 having the highest affinity (KD) of 51 pM dominantly localized around CD31-positive tumor vascular cells, whereas the relatively low-affinity binders, including rA11, rAC1, and rEgA, evenly distributed throughout the tumor (Figure 5F). Here, RAC1 is linked to neoplasm.